Status:
COMPLETED
An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis
Lead Sponsor:
Pfizer
Conditions:
Chronic Prostatitis With Chronic Pelvic Pain Syndrome
Eligibility:
MALE
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine whether tanezumab is effective in the treatment of pain associated with chronic prostatitis.
Eligibility Criteria
Inclusion
- Diagnosis of chronic prostatitis
- Male adults at least 18 years of age
- Moderate to severe chronic prostatitis, with an average pain score above a pre-defined level
- To use contraception.
Exclusion
- History of symptoms for less than 3 of the last 6 months
- History of recurrent urinary tract infections, or genito-urinary cancer
- Use of finasteride or dutasteride within 6 months.
- History of hepatitis B, C or human immunodeficiency virus (HIV)
Key Trial Info
Start Date :
March 25 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 17 2010
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT00826514
Start Date
March 25 2009
End Date
March 17 2010
Last Update
May 13 2021
Active Locations (44)
Enter a location and click search to find clinical trials sorted by distance.
1
Alabama Research Center, LLC
Birmingham, Alabama, United States, 35209
2
The Kirklin Clinic
Birmingham, Alabama, United States, 35233
3
University of Alabama Birmingham
Birmingham, Alabama, United States, 35294-3411
4
Valley Urologic Associates
Goodyear, Arizona, United States, 85395